Organoid profiling identifies common responders to chemotherapy in pancreatic cancer H Tiriac, P Belleau, DD Engle, D Plenker, A Deschênes, TDD Somerville, ... Cancer discovery 8 (9), 1112-1129, 2018 | 859 | 2018 |
Intestinal microbiota in patients with nonalcoholic fatty liver disease M Mouzaki, EM Comelli, BM Arendt, J Bonengel, SK Fung, SE Fischer, ... Hepatology 58 (1), 120-127, 2013 | 856 | 2013 |
Genomics-driven precision medicine for advanced pancreatic cancer: early results from the COMPASS trial KL Aung, SE Fischer, RE Denroche, GH Jang, A Dodd, S Creighton, ... Clinical Cancer Research 24 (6), 1344-1354, 2018 | 526 | 2018 |
Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution M Chan-Seng-Yue, JC Kim, GW Wilson, K Ng, EF Figueroa, GM O’Kane, ... Nature genetics 52 (2), 231-240, 2020 | 489 | 2020 |
Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis T Kumagi, M Guindi, SE Fischer, T Arenovich, R Abdalian, C Coltescu, ... Official journal of the American College of Gastroenterology| ACG 105 (10 …, 2010 | 398 | 2010 |
Bile acids and dysbiosis in non-alcoholic fatty liver disease M Mouzaki, AY Wang, R Bandsma, EM Comelli, BM Arendt, L Zhang, ... PloS one 11 (5), e0151829, 2016 | 383 | 2016 |
Identification of driver genes in hepatocellular carcinoma by exome sequencing SP Cleary, WR Jeck, X Zhao, K Chen, SR Selitsky, GL Savich, TX Tan, ... Hepatology 58 (5), 1693-1702, 2013 | 352 | 2013 |
Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n‐3 and n‐6 polyunsaturated fatty acids BM Arendt, EM Comelli, DWL Ma, W Lou, A Teterina, TH Kim, SK Fung, ... Hepatology 61 (5), 1565-1578, 2015 | 296 | 2015 |
Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis G Sapisochin, A Barry, M Doherty, S Fischer, N Goldaracena, R Rosales, ... Journal of hepatology 67 (1), 92-99, 2017 | 293 | 2017 |
IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations PA Vlachou, K Khalili, HJ Jang, S Fischer, GM Hirschfield, TK Kim Radiographics 31 (5), 1379-1402, 2011 | 279 | 2011 |
Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance HE Da Silva, A Teterina, EM Comelli, A Taibi, BM Arendt, SE Fischer, ... Scientific reports 8 (1), 1466, 2018 | 260 | 2018 |
Spatially confined sub-tumor microenvironments in pancreatic cancer BT Grünwald, A Devisme, G Andrieux, F Vyas, K Aliar, CW McCloskey, ... Cell 184 (22), 5577-5592. e18, 2021 | 258 | 2021 |
GATA6 expression distinguishes classical and basal-like subtypes in advanced pancreatic cancer GM O’Kane, BT Grünwald, GH Jang, M Masoomian, S Picardo, RC Grant, ... Clinical Cancer Research 26 (18), 4901-4910, 2020 | 249 | 2020 |
Application of immunohistochemistry to thyroid neoplasms S Fischer, SL Asa Archives of pathology & laboratory medicine 132 (3), 359-372, 2008 | 220 | 2008 |
The use of cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver R Jain, S Fischer, S Serra, R Chetty Applied Immunohistochemistry & Molecular Morphology 18 (1), 9-15, 2010 | 204 | 2010 |
Integration of genomic and transcriptional features in pancreatic cancer reveals increased cell cycle progression in metastases AA Connor, RE Denroche, GH Jang, M Lemire, A Zhang, ... Cancer cell 35 (2), 267-282. e7, 2019 | 184 | 2019 |
Single‐cell, single‐nucleus, and spatial RNA sequencing of the human liver identifies cholangiocyte and mesenchymal heterogeneity TS Andrews, J Atif, JC Liu, CT Perciani, XZ Ma, C Thoeni, M Slyper, ... Hepatology Communications 6 (4), 821-840, 2022 | 139 | 2022 |
Cell-type specific gene expression signature in liver underlies response to interferon therapy in chronic hepatitis C infection L Chen, I Borozan, J Sun, M Guindi, S Fischer, J Feld, N Anand, ... Gastroenterology 138 (3), 1123-1133. e3, 2010 | 124 | 2010 |
A four-chemokine signature is associated with a T-cell–inflamed phenotype in primary and metastatic pancreatic cancer JM Romero, B Grünwald, GH Jang, PP Bavi, A Jhaveri, M Masoomian, ... Clinical Cancer Research 26 (8), 1997-2010, 2020 | 120 | 2020 |
Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma C Sandroussi, LA Dawson, M Lee, M Guindi, S Fischer, A Ghanekar, ... Transplant international 23 (3), 299-306, 2010 | 110 | 2010 |